Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-007278
Filing Date
2025-01-21
Accepted
2025-01-21 16:30:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11036
2 EX-24.1 ck0001669811-ex24_1.pdf EX-24.1 135653
3 EX-24.2 ck0001669811-ex24_2.pdf EX-24.2 135633
  Complete submission text file 0000950170-25-007278.txt   386670
Mailing Address 2765 SAND HILL RD MENLO PARK CA 94025
Business Address 2765 SAND HILL RD MENLO PARK CA 94025 650-854-8092
Canaan XI L.P. (Filed by) CIK: 0001712417 (see all company filings)

EIN.: 981377917 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Subject) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92865 | Film No.: 25542823
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)